A cost-benefit analysis of lipid standardization in the United States. [electronic resource]
Producer: 20120228Description: A136 p. digitalISSN:- 1545-1151
- Cardiovascular Diseases -- economics
- Cause of Death -- trends
- Cost-Benefit Analysis
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- economics
- Lipids -- blood
- Logistic Models
- Middle Aged
- Program Evaluation
- Quality-Adjusted Life Years
- Reference Standards
- Retrospective Studies
- United States -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.